Study of SQZ-PBMC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors

NCT04084951 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Adult Solid Tumor

Interventions

BIOLOGICAL: SQZ-PBMC-HPV
DRUG: Atezolizumab
DRUG: Ipilimumab
DRUG: Nivolumab

Sponsor

SQZ Biotechnologies